Background: Autosomal dominant hereditary angioedema (HAE) results in episodes of subcutaneous edema in any body part and/or submucosal edema of the upper respiratory or gastrointestinal tracts. This disorder is caused by mutations in the C1NH gene, many of which have been described primarily in European patients. However, the genetic cause of HAE in Middle Eastern Arab patients has not yet been determined. Methods: Four unrelated Arab families, in which 15 patients were diagnosed with HAE, were studied. DNA from 13 patients was analyzed for mutations in the C1NH gene by DNA sequencing. Results: Three novel and 2 recurrent mutations were identified in the C1NH gene of HAE patients. In family 1, the patient was heterozygous for a novel c.856C>T and a recurrent c.1361T>A missense mutation encoding for p.Arg264Cys and p.Val432Glu, respectively. In patients from family 2, a novel c.509C>T missense mutation encoding for a p.Ser148Phe was identified. In patients from family 3, a novel c.1142delC nonsense mutation encoding for a p.Ala359AlafsX15 was discovered. In family 4, a recurrent c.1397G>A missense mutation encoding for a p.Arg444His was present. Conclusion: This is the first ever report of C1NH gene mutations in Middle Eastern Arab patients. Our study suggests that, despite the numerous existing mutations in the C1NH gene, there are novel and recurrent mutations in HAE patients of non-European origin. We conclude that the spectrum of C1NH gene mutations in HAE patients is wider due to the likely presence of novel and recurrent mutations in patients of other ethnicities.

Keywords:
C1NH gene, Hereditary angioedema, Missense mutation, Nonsense mutation
1.
Blanch A, Roche O, Lopez-Granados E, Fontan G, Lopez-Trascasa M: Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations. Hum Mutat 2002;20:405–406.
2.
Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M: First case of homozygous c1 inhibitor deficiency. J Allergy Clin Immunol 2006;118:1330–1335.
3.
Davis AE 3rd, Aulak K, Parad RB, et al: C1 inhibitor hinge region mutations produce dysfunction by different mechanisms. Nat Genet 1992;1:354–358.
4.
Gosswein T, Kocot A, Emmert G, et al: Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema. Cytogenet Genome Res 2008;121:181–188.
5.
Kalmar L, Bors A, Farkas H, Vas S, Fandl B, Varga L, Fust G, Tordai A: Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema. Hum Mutat 2003;22:498.
6.
Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M: Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlates. Mol Immunol 2008;45:3536–3544.
7.
Roche O, Blanch A, Duponchel C, Fontan G, Tosi M, Lopez-Trascasa M: Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort. Hum Mutat 2005;26:135–144.
8.
Skriver K, Radziejewska E, Silbermann JA, Donaldson VH, Bock SC: CpG mutations in the reactive site of human C1 inhibitor. J Biol Chem 1989;264:3066–3071.
9.
Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, Tosi M: Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 2000;106:1147–1154.
10.
Siddique Z, McPhaden AR, Whaley K: Type II hereditary angio-oedema associated with two mutations in one allele of the C1-inhibitor gene around the reactive-site coding region. Hum Hered 1992;42:298–301.
11.
Kalmar L, Hegedus T, Farkas H, Nagy M, Tordai A: HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat 2005;25:1–5.
12.
Agostoni A, Aygoren-Pursun E, Binkley KE, et al: Hereditary and acquired angioedema: problems and progress. Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004;114:S51–S131.
13.
Kessler HH, Muhlbauer G, Stelzl E, Daghofer E, Santner BI, Marth E: Fully automated nucleic acid extraction: MagNA pure LC. Clin Chem 2001;47:1124–1126.
14.
Chang YF, Imam JS, Wilkinson MF: The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 2007;76:51–74.
15.
Bissler JJ, Aulak KS, Donaldson VH, Rosen FS, Cicardi M, Harrison RA, Davis AE 3rd: Molecular defects in hereditary angioneurotic edema. Proc Assoc Am Physicians 1997;109:164–173.
16.
Zuraw BL, Herschbach J: Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol 2000;105:541–546.
17.
Freiberger T, Kolarova L, Mejstrik P, Vyskocilova M, Kuklinek P, Litzman J: Five novel mutations in the C1 inhibitor gene (C1NH) leading to a premature stop codon in patients with type I hereditary angioedema. Hum Mutat 2002;19:461.
18.
Cumming SA, Halsall DJ, Ewan PW, Lomas DA: The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angio-oedema. J Med Genet 2003;40:e114.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.